Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $1,056,916 (100.0% shares, 0.0% debt)

Holdings (29)

BMRN BIOMARIN PHARMACEUTICAL INC 15.3%
Value ($000) $162,010 Shares 1,831,035 Est. Cost $83.16 Unrealized +7.0%
INSM INSMED INC 14.1%
Value ($000) $148,710 Shares 5,889,491 Est. Cost $17.79 Unrealized +28.5%
UTHR UNITED THERAPEUTICS CORP 12.3%
Value ($000) $130,080 Shares 575,907 Est. Cost $89.23 Unrealized +158.1%
FOLD AMICUS THERAPEUTICS INC 12.1%
Value ($000) $127,972 Shares 10,524,022 Est. Cost $9.63 Unrealized +34.0%
BIIB BIOGEN INC 9.3%
Value ($000) $97,993 Shares 381,282 Est. Cost $264.98 Unrealized +0.9%
PRTA PROTHENA CORP PLC 7.6%
Value ($000) $79,972 Shares 1,657,458 Est. Cost $21.46 Unrealized +176.9%
REVANCE THERAPEUTICS INC 5.7%
Value ($000) $59,972 Shares 5,228,609 Est. Cost $21.40 Unrealized
STAA STAAR SURGICAL CO 5.2%
Value ($000) $55,240 Shares 1,374,822 Est. Cost $24.23 Unrealized +93.3%
ACAD ACADIA PHARMACEUTICALS INC 4.7%
Value ($000) $50,137 Shares 2,405,793 Est. Cost $28.41 Unrealized -4.4%
SAGE THERAPEUTICS INC 2.0%
Value ($000) $20,699 Shares 1,005,776 Est. Cost $42.84 Unrealized
EHTH EHEALTH INC 1.9%
Value ($000) $20,271 Shares 2,739,379 Est. Cost $38.13 Unrealized -79.4%
ALGN ALIGN TECHNOLOGY INC 1.6%
Value ($000) $17,008 Shares 55,705 Est. Cost $149.18 Unrealized +131.6%
ALKS ALKERMES PLC 1.6%
Value ($000) $16,901 Shares 603,400 Est. Cost $22.36 Unrealized +31.1%
SRPT SAREPTA THERAPEUTICS INC 1.1%
Value ($000) $11,398 Shares 94,030 Est. Cost $128.81 Unrealized -12.3%
NVCR NOVOCURE LTD 1.0%
Value ($000) $10,663 Shares 660,275 Est. Cost $58.84 Unrealized -51.0%
ANAB ANAPTYSBIO INC 0.7%
Value ($000) $7,745 Shares 431,224 Est. Cost $19.06 Unrealized +0.1%
KARYOPHARM THERAPEUTICS INC 0.7%
Value ($000) $7,606 Shares 5,675,876 Est. Cost $16.36 Unrealized
NEVRO CORP 0.7%
Value ($000) $7,435 Shares 386,832 Est. Cost $22.21 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 0.6%
Value ($000) $6,862 Shares 472,600 Est. Cost $16.84 Unrealized +12.3%
GOSS GOSSAMER BIO INC 0.5%
Value ($000) $5,438 Shares 6,530,288 Est. Cost $1.61 Unrealized -28.6%
CYTK CYTOKINETICS INC 0.3%
Value ($000) $3,291 Shares 111,717 Est. Cost $6.71 Unrealized +396.1%
RLMD RELMADA THERAPEUTICS INC 0.2%
Value ($000) $2,197 Shares 732,400 Est. Cost $3.27 Unrealized -9.2%
MIRM MIRUM PHARMACEUTICALS INC 0.2%
Value ($000) $2,045 Shares 64,700 Est. Cost $15.56 Unrealized +76.0%
TVTX TRAVERE THERAPEUTICS INC 0.1%
Value ($000) $1,485 Shares 166,069 Est. Cost $23.56 Unrealized -40.1%
VNDA VANDA PHARMACEUTICALS INC 0.1%
Value ($000) $1,205 Shares 278,985 Est. Cost $11.21 Unrealized -50.5%
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value ($000) $1,074 Shares 160,800 Est. Cost $7.10 Unrealized +4.6%
KEZAR LIFE SCIENCES INC 0.1%
Value ($000) $781 Shares 656,200 Est. Cost $5.16 Unrealized
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.0%
Value ($000) $381 Shares 27,100 Est. Cost $39.74 Unrealized -50.7%
URGN UROGEN PHARMA LTD 0.0%
Value ($000) $343 Shares 24,500 Est. Cost $27.01 Unrealized -40.6%